#FDA approves #Cyltezo as first interchangeable #biosimilar for #Humira for use in patients with #inflammatory dise… https://t.co/IcaV7UQ0Ay
#FDA approves #Cyltezo as first interchangeable #biosimilar for #Humira for use in patients with #inflammatory dise… https://t.co/IcaV7UQ0Ay